Issue |
J Extra Corpor Technol
Volume 40, Number 4, December 2008
|
|
---|---|---|
Page(s) | 271 - 274 | |
DOI | https://doi.org/10.1051/ject/200840271 | |
Published online | 15 December 2008 |
Case Reports
Long-term Extracorporeal Circulation Management: The Role of Low- and High-range Heparin ACT Tests
Address correspondence to: Daniel Herbst, CCP, Department of Cardiac Sciences, Mail Code 1413, King Fahad Hospital, PO Box 22490, Riyadh, Saudi Arabia. E-mail: herbstd@ngha.med.sa
Modern management of extracorporeal circulation, especially during long-term support of post-cardiac surgical patients, remains challenging and requires optimal care of the patient’s fluid balance and coagulation hemostasis for its successful outcome. The activated clotting time assay is one of the tests used to manage extracorporeal circulation and is available in a low- and high-range level. The question of which assay is more appropriate for procedures that require low to moderate heparin dosing is still unclear. We report our experience with a neonate diagnosed with hypoplastic left heart syndrome who needed emergent extracorporeal membrane oxygenation support for 13 days after Norwood stage I palliation using a Sano shunt. Although successful, bleeding complications prompted us to review our strategy for management of coagulation hemostasis.
Key words: extracorporeal / membrane / oxygenation / heparin / clotting / thrombelastograph
© 2008 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.